-
Cost-Effectiveness Analysis of Generalizing the Lp(a) Dosing in Secondary Prevention in a Population of French Patients With Cardiovascular Disease
Sep 9, 2025, 16:22 PM -
Quantification of Life-Cycle Value Using Early Modeling to Support RD and Strategy Decisions: A Case Study of a Polymeric Heart Valve
Sep 9, 2025, 16:22 PM -
Identifying Factors Associated With Involvement in Healthcare Decisions in Wales
Sep 9, 2025, 16:22 PM -
Burden Of Disease, Healthcare Resource Use and Costs of Respiratory Syncytial Virus Among Adults in Spain in 2021-2023 in the Hospital Setting: A Real-World Retrospective Observational Study of Four Hospitals
Sep 9, 2025, 16:22 PM -
Quality of Systematic Reviews With Network Meta-Analyses on JAK Inhibitors in the Treatment of Rheumatoid Arthritis: Application of the AMSTAR 2 Scale
Sep 9, 2025, 16:22 PM -
Assessing Time Tradeoff Utilities in Health States of Organic Hypogonadotropic Hypogonadism: A Pilot Study in Brazil
Sep 9, 2025, 16:22 PM -
What Does the New ILAP Refresh Mean for Pharmaceutical Development and Patient Access in the UK?
Sep 9, 2025, 16:22 PM -
Healthcare Costs in People With Type 2 Diabetes Remaining on or Escalating From Basal-Supported Oral Therapy: A 5-Year German Statutory Health Insurance Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Quality-Adjusted Time Without Symptoms or Toxicity Q-TWiST Estimates in Previously Treated HER2-Positive Biliary Tract Carcinoma (BTC) Using the Zanidatamab HERIZON-BTC-01 Study
Sep 9, 2025, 16:22 PM -
Historical Shifts in Birth Month Distribution in Japan and the Impacts on Health Outcome Studies
Sep 9, 2025, 16:22 PM -
The Health Economic Case for AI in Radiology: A Systematic Review and Appraisal of Evaluation Quality and Methods
Sep 9, 2025, 16:22 PM -
AI Powered SQL for Real-World Data: From Questions to Insights
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Resource Utilization Among Patients With Immune Thrombocytopenia: A Real-World Survey
Sep 9, 2025, 16:22 PM -
Economic Evaluation Of Cefiderocol for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii in Italy Using Real-World Evidence
Sep 9, 2025, 16:22 PM -
Accounting for Bereavement in NICE Pediatric Health Technology Appraisals: A Review of the Inclusion of Caregiver Health Utilities After the Death of a Child
Sep 9, 2025, 16:22 PM -
How Do National Systems Take the JCA Into Account Navigating Specificities to Achieve Accelerated Patient Access?
Sep 9, 2025, 16:22 PM -
A Data-Driven Framework for Rare Disease Protocol Design: Integrating Real-World Evidence, Patient Perspectives, and Regulatory Guidance
Sep 9, 2025, 16:22 PM -
Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions
Sep 9, 2025, 16:22 PM -
HTA Life-Cycle Concepts: The Need for HTA Bodies to Grow Beyond Their Traditional Scope
Sep 9, 2025, 16:22 PM -
Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy
Sep 9, 2025, 16:22 PM
